Emily E Ricotta1, Yi Ling Lai1, Ahmed Babiker2, Jeffrey R Strich3,4, Sameer S Kadri3, Michail S Lionakis5, D Rebecca Prevots1, Jennifer Adjemian1,4. 1. Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. 2. Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA. 3. Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. 4. United States Public Health Service, Commissioned Corps, Rockville, Maryland, USA. 5. Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
BACKGROUND: Invasive candidiasis (IC) is a growing concern among US healthcare facilities. A large-scale study evaluating incidence and trends of IC in the United States by species and body site is needed to understand the distribution of infection. METHODS: An electronic medical record database was used to calculate incidence and trends of IC in the United States by species and infection site from 2009 through 2017. Hospital incidence was calculated using total unique inpatient hospitalizations in hospitals reporting at least 1 Candida case as the denominator. IC incidence trends were assessed using generalized estimating equations with exchangeable correlation structure to fit Poisson regression models, controlling for changes in hospital characteristics and case mix over time. RESULTS: Candida albicans remains the leading cause of IC in the United States, followed by Candida glabrata. The overall incidence of IC was 90/100 000 patients, which did not change significantly over time. There were no changes in incidence among C. albicans, C. glabrata, C. parapsilosis, or C. tropicalis; the incidence of other Candida spp. as a whole increased 7.2% annually. While there was no change in candidemia 2009-2017, abdominal and nonabdominal sterile site IC increased significantly. CONCLUSIONS: Nonbloodstream IC is increasing in the United States. Understanding the epidemiology of IC should facilitate improved management of infected patients. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND: Invasive candidiasis (IC) is a growing concern among US healthcare facilities. A large-scale study evaluating incidence and trends of IC in the United States by species and body site is needed to understand the distribution of infection. METHODS: An electronic medical record database was used to calculate incidence and trends of IC in the United States by species and infection site from 2009 through 2017. Hospital incidence was calculated using total unique inpatient hospitalizations in hospitals reporting at least 1 Candida case as the denominator. IC incidence trends were assessed using generalized estimating equations with exchangeable correlation structure to fit Poisson regression models, controlling for changes in hospital characteristics and case mix over time. RESULTS: Candida albicans remains the leading cause of IC in the United States, followed by Candida glabrata. The overall incidence of IC was 90/100 000 patients, which did not change significantly over time. There were no changes in incidence among C. albicans, C. glabrata, C. parapsilosis, or C. tropicalis; the incidence of other Candida spp. as a whole increased 7.2% annually. While there was no change in candidemia 2009-2017, abdominal and nonabdominal sterile site IC increased significantly. CONCLUSIONS: Nonbloodstream IC is increasing in the United States. Understanding the epidemiology of IC should facilitate improved management of infected patients. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Entities:
Keywords:
electronic health record; epidemiology; hospital infections; invasive candidiasis
Authors: Daniel Diekema; Sophie Arbefeville; Linda Boyken; Jennifer Kroeger; Michael Pfaller Journal: Diagn Microbiol Infect Dis Date: 2012-05 Impact factor: 2.803
Authors: Barbara D Alexander; Melissa D Johnson; Christopher D Pfeiffer; Cristina Jiménez-Ortigosa; Jelena Catania; Rachel Booker; Mariana Castanheira; Shawn A Messer; David S Perlin; Michael A Pfaller Journal: Clin Infect Dis Date: 2013-03-13 Impact factor: 9.079
Authors: Mariana Castanheira; Shawn A Messer; Paul R Rhomberg; Michael A Pfaller Journal: Diagn Microbiol Infect Dis Date: 2016-02-09 Impact factor: 2.803
Authors: Ryan P Fagan; Jonathan R Edwards; Benjamin J Park; Scott K Fridkin; Shelley S Magill Journal: Infect Control Hosp Epidemiol Date: 2013-07-16 Impact factor: 3.254
Authors: Hilmar Wisplinghoff; Jenny Ebbers; Lea Geurtz; Danuta Stefanik; Yvette Major; Michael B Edmond; Richard P Wenzel; Harald Seifert Journal: Int J Antimicrob Agents Date: 2013-10-12 Impact factor: 5.283
Authors: Peter G Pappas; Michail S Lionakis; Maiken Cavling Arendrup; Luis Ostrosky-Zeichner; Bart Jan Kullberg Journal: Nat Rev Dis Primers Date: 2018-05-11 Impact factor: 52.329
Authors: Mitsuru Toda; Sabrina R Williams; Elizabeth L Berkow; Monica M Farley; Lee H Harrison; Lindsay Bonner; Kaytlynn M Marceaux; Rosemary Hollick; Alexia Y Zhang; William Schaffner; Shawn R Lockhart; Brendan R Jackson; Snigdha Vallabhaneni Journal: MMWR Surveill Summ Date: 2019-09-27
Authors: Lisa M Mayer; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; Nicholas G Evans; D Rebecca Prevots; Emily E Ricotta Journal: Open Forum Infect Dis Date: 2022-08-03 Impact factor: 4.423
Authors: Rebecca A Drummond; Jigar V Desai; Emily E Ricotta; Muthulekha Swamydas; Clay Deming; Sean Conlan; Mariam Quinones; Veronika Matei-Rascu; Lozan Sherif; David Lecky; Chyi-Chia R Lee; Nathaniel M Green; Nicholas Collins; Adrian M Zelazny; D Rebecca Prevots; David Bending; David Withers; Yasmine Belkaid; Julia A Segre; Michail S Lionakis Journal: Cell Host Microbe Date: 2022-05-13 Impact factor: 31.316
Authors: Anabel Piqueras; Lakshmi Ganapathi; Jane F Carpenter; Thomas Rubio; Thomas J Sandora; Kelly B Flett; Julia R Köhler Journal: J Fungi (Basel) Date: 2021-01-22
Authors: Victoria C Grant; Kenneth Nguyen; Sasha Rodriguez; Anna Y Zhou; Jacinda C Abdul-Mutakabbir; Karen K Tan Journal: Trop Med Infect Dis Date: 2022-02-03
Authors: Marcio Nucci; Gloria Barreiros; Luiz Felipe Guimarães; Vitor A S Deriquehem; Anna Carla Castiñeiras; Simone A Nouér Journal: Mycoses Date: 2020-12-10 Impact factor: 4.931